CS10(cagr i l int ide 5mg+Semag lut ide 5mg)
- Createtime: 2026-06-11
- Updatetime: 2026-06-11
Product Details
| useage |
Research use only. Blend of Cagrilintide (AMYR/CTR agonist) and Semaglutide (GLP-1R agonis
|
| deliveryInfo |
|
| appearance |
White lyophilized powder
|
| aliasen |
|
| supplyCapacity |
100G/Day
|
| harbor |
Hong Kong
|
| minorder |
1G
|
| Payment method |
Alibaba, PayPal, USDT, bank card, Western Union remittance
|
| Delivery date |
7 days
|
| Whatsapp |
86 131 7158 8872
|
Name: Cagrilintide CAS Registry number: 1415456-99-3 Molecular Formula: C???H???N??O??S? Molecular Weight: ~4393.3 Da Purity: ≥99% (by HPLC) Appearance: White lyophilized powder Packing: 10 vials/box Storage Conditions: Store at -20℃ in a dry, dark place; avoid repeated freeze-thaw cycles.
Brief Introduction: Cagrilintide is a long-acting, synthetic dual agonist of the amylin receptor (AMYR) and calcitonin receptor (CTR). It is designed for research use only, particularly in the fields of metabolic regulation, obesity, and type 2 diabetes studies.
Main Research Applications: 1. Obesity and appetite regulation research: Used in preclinical models to investigate mechanisms of appetite suppression, food intake reduction, and body weight control. 2. Metabolic syndrome research: Applied in studies of glucose homeostasis, insulin sensitivity, and lipid metabolism regulation. 3. Combination therapy research: Commonly studied in combination with GLP-1R agonists (e.g., Semaglutide) to explore synergistic effects on weight loss and metabolic improvement.
Note: This product is for laboratory research use only. It is not intended for human or animal therapeutic use, clinical trials, or any form of in vivo administration without prior ethical approval and regulatory authorization.